TY - JOUR AU - Zhou, Ling AU - Lu, Dao-pei PY - 2019 DA - 2019/02/08 TI - Immune reconstitution of HLA-A*0201/BMLF1- and HLA-A*1101/LMP2-specific Epstein Barr virus cytotoxic T lymphocytes within 90 days after haploidentical hematopoietic stem cell transplantation JO - Virology Journal SP - 19 VL - 16 IS - 1 AB - Haploidentical hematopoietic stem cell transplant (haplo-HSCT) recipients are at high risk for Epstein Barr virus (EBV)-related diseases. EBV-specific CD8+ cytotoxic T cells can control EBV-infected B cell expansion; however, no studies have investigated EBV-specific immune reconstitution after HSCT, particularly haplo-HSCT. Therefore, in this study, we aimed to characterize EBV-specific immune cell reconstitution after haplo-HSCT. SN - 1743-422X UR - https://doi.org/10.1186/s12985-019-1123-y DO - 10.1186/s12985-019-1123-y ID - Zhou2019 ER -